Dynamic correlation of apoptosis and immune activation during treatment of HIV infection
- PMID: 10381636
- DOI: 10.1038/sj.cdd.4400509
Dynamic correlation of apoptosis and immune activation during treatment of HIV infection
Abstract
T cells from HIV infected patients undergo spontaneous apoptosis at a faster rate than those from uninfected patients, are abnormally susceptible to activation induced cell death (AICD), and undergo increased apoptosis in response to Fas receptor ligation. These observations have led to the hypothesis CD4 T cell apoptosis may be a mechanism of CD4 T cell depletion and the pathogenesis of AIDS. Successful treatment of HIV infected patients is accompanied by quantitative and qualitative improvements in immune function reflecting at least partial reversibility of the underlying pathogenesis of HIV. In this report we correlate improvements in markers of immune function with a decrease in apoptosis, and changes in its regulation. Therapy with nelfinavir plus saquinavir in combination with two nucleoside analogue inhibitors of reverse transcriptase dramatically reduces plasma viremia and increases CD4 T cell counts. Coincident with these improvements, CD38 and HLA-DR coexpression on both CD4 and CD8 T cells decrease, and CD45RA and CD62L coexpression increase. Furthermore, spontaneous apoptosis decreases in both CD4 and CD8 T cells (CD4 apoptosis 17.4 vs 2.6%, P=0.005; CD8 apoptosis 15.0 vs 1.0%, P<0.001), as does both Fas mediated apoptosis (CD4 apoptosis 19.0 vs 3.5%, P=0.03; CD8 apoptosis 13.7 vs 1.5%, P=0.002) and CD3 induced AICD (CD4 apoptosis 13.7 vs 3.2%, P=0.001; CD8 apoptosis 29 vs 2.2%, P=0.08). Changes in apoptosis are not associated with changes in Fas receptor expression, but are significantly correlated with changes in activation marker profiles. Although this suggests a possible regulatory role for the apoptosis inhibitory protein FLIP, direct assessment did not reveal quantitative differences in FLIP expression between apoptosis resistant PBL's from HIV negative patients, and apoptosis sensitive PBL's from HIV positive patients. These findings support the hypothesis that apoptosis mediates HIV induced CD4 T cell depletion, but indicate the need for further studies into the molecular regulation of HIV induced apoptosis.
Similar articles
-
Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.Antivir Ther. 2004 Apr;9(2):197-204. Antivir Ther. 2004. PMID: 15134181 Clinical Trial.
-
Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype.J Immunol. 1997 Mar 15;158(6):2964-76. J Immunol. 1997. PMID: 9058836
-
Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection.J Immunol. 1996 Mar 15;156(6):2282-93. J Immunol. 1996. PMID: 8690919
-
HIV, cytokines and programmed cell death. A subtle interplay.Ann N Y Acad Sci. 2000;926:30-45. doi: 10.1111/j.1749-6632.2000.tb05596.x. Ann N Y Acad Sci. 2000. PMID: 11193039 Review.
-
Influence of mitochondrial control of apoptosis on the pathogenesis, complications and treatment of HIV infection.Biochimie. 2002 Feb-Mar;84(2-3):251-64. doi: 10.1016/s0300-9084(02)01378-0. Biochimie. 2002. PMID: 12022956 Review.
Cited by
-
Effect of maraviroc on HIV disease progression-related biomarkers.Antimicrob Agents Chemother. 2012 Nov;56(11):5858-64. doi: 10.1128/AAC.01406-12. Epub 2012 Sep 4. Antimicrob Agents Chemother. 2012. PMID: 22948867 Free PMC article.
-
Apoptosis of uninfected cells induced by HIV envelope glycoproteins.Retrovirology. 2004 Jun 23;1:12. doi: 10.1186/1742-4690-1-12. Retrovirology. 2004. PMID: 15214962 Free PMC article. Review.
-
Apoptosis characterization in mononuclear blood leukocytes of HIV patients during dengue acute disease.Sci Rep. 2020 Apr 14;10(1):6351. doi: 10.1038/s41598-020-62776-4. Sci Rep. 2020. PMID: 32286360 Free PMC article.
-
Nelfinavir: an update on its use in HIV infection.Drugs. 2000 Mar;59(3):581-620. doi: 10.2165/00003495-200059030-00014. Drugs. 2000. PMID: 10776836 Review.
-
Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.AIDS. 2015 Oct 23;29(16):2121-9. doi: 10.1097/QAD.0000000000000810. AIDS. 2015. PMID: 26544577 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous